Roche Working ‘Day and Night’ on Covid Treatment Production: CEO

Feb.04 -- Roche Holding AG Chief Executive Officer Severin Schwan said the company is working “day and night” to boost production capacity for the Covid-19 antibody cocktail it’s developing with Regeneron Pharmaceuticals Inc. He spoke on “Bloomberg Daybreak: Europe.”